| 1GLO | A: | CRYSTAL STRUCTURE OF CYS25SER MUTANT OF HUMAN CATHEPSIN S |
| 1MS6 | A: | DIPEPTIDE NITRILE INHIBITOR BOUND TO CATHEPSIN S. |
| 1NPZ | A:; B: | CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES |
| 1NQC | A: | CRYSTAL STRUCTURES OF CATHEPSIN S INHIBITOR COMPLEXES |
| 2F1G | A:; B: | CATHEPSIN S IN COMPLEX WITH NON-COVALENT 2-(BENZOXAZOL-2-YLAMINO)-ACETAMIDE |
| 2FYE | A: | MUTANT HUMAN CATHEPSIN S WITH IRREVERSIBLE INHIBITOR CRA-14013 |
| 2G6D | A:1-211 | HUMAN CATHEPSIN S MUTANT WITH VINYL SULFONE INHIBITOR CRA-14009 |
| 2G7Y | A:; B: | HUMAN CATHEPSIN S WITH INHIBITOR CRA-16981 |
| 2H7J | A:; B: | CRYSTAL STRUCTURE OF CATHEPSIN S IN COMPLEX WITH A NONPEPTIDIC INHIBITOR. |
| 2HH5 | A:; B: | CRYSTAL STRUCTURE OF CATHEPSIN S IN COMPLEX WITH A ZINC MEDIATED NON-COVALENT ARYLAMINOETHYL AMIDE |
| 2HHN | A:; B: | CATHEPSIN S IN COMPLEX WITH NON COVALENT ARYLAMINOETHYL AMIDE. |
| 2HXZ | A:; B:; C: | CRYSTAL STRUCTURE OF CATHEPSIN S IN COMPLEX WITH A NONPEPTIDIC INHIBITOR (HEXAGONAL SPACEGROUP) |
| 2OP3 | A:; B: | THE STRUCTURE OF CATHEPSIN S WITH A NOVEL 2-ARYLPHENOXYACETALDEHYDE INHIBITOR DERIVED BY THE SUBSTRATE ACTIVITY SCREENING (SAS) METHOD |
| 2R9M | A:; B: | CATHEPSIN S COMPLEXED WITH COMPOUND 15 |
| 2R9N | A:; B: | CATHEPSIN S COMPLEXED WITH COMPOUND 26 |
| 2R9O | A:; B: | CATHEPSIN S COMPLEXED WITH COMPOUND 8 |
| 3IEJ | A:; B: | PYRAZOLE-BASED CATHEPSIN S INHIBITORS WITH ARYLALKYNES AS P1 BINDING ELEMENTS |
| 3KWN | A:; B: | CATHEPSIN S IN COMPLEX WITH THIOETHER ACETAMIDE P3 INHIBITOR |
| 3MPE | A:; B: | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN-S C25S MUTANT WITH BOUND DRUG |
| 3MPF | A:; B: | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN-S C25S MUTANT WITH BOUND DRUG |
| 3N3G | A:; B: | 4-(3-TRIFLUOROMETHYLPHENYL)-PYRIMIDINE-2-CARBONITRILE AS CATHEPSIN S INHIBITORS: N3, NOT N1 IS CRITICALLY IMPORTANT |
| 3N4C | A:; B: | 6-PHENYL-1H-IMIDAZO[4,5-C]PYRIDINE-4-CARBONITRILE AS CATHEPSIN S INHIBITORS |
| 3OVX | A:; B: | CATHEPSIN S IN COMPLEX WITH A COVALENT INHIBITOR WITH AN ALDEHYDE WARHEAD |
)
)